FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persistersMengjiao Li, Noriko Gotoh, Yasuto Takeuchi et al.|Journal of Clinical Investigation|2023Cited by 29